Norovirus is highly contagious and is the most common cause of acute gastroenteritis worldwide1,2
Globally, an estimated 685 million cases of norovirus are seen annually, including 200 million cases amongst children under 51,2
Norovirus causes an estimated 200,000 deaths per year, including 50,000 child deaths1,2
Every year, this virus is estimated to cost $60 billion worldwide due to healthcare costs and lost productivity1,2
Norovirus outbreaks in healthcare institutions require immediate implementation of infection control measures to avoid ward closures1,2
The Solution
Xpert Norovirus detects genotype I (GI) and genotype II (GII), which are responsible for the majority of infections
Xpert Norovirus provides rapid results to support timely infection control measures and outbreak response3
On-demand identification supports outbreak management enabling fast contact tracing to manage onward transmission4
The Impact
In published implementation studies, Xpert Norovirus PCR testing has been evaluated in routine healthcare settings to assess its potential role in supporting timely laboratory diagnosis. These studies report that fast molecular results may support infection control workflows when used as part of established institutional practices.³ ⁵ ⁶ Across reported study sites, implementation of Xpert Norovirus testing was associated with reduced laboratory turnaround times compared to prior diagnostic approaches under those specific conditions.
Reported findings included:
An 89% reduction in turnaround time (from 22 hours to 2.4 hours) within the evaluated study settings⁵